Tecovirimat for monkeypox

Tecovirimat is an antiviral drug with activity against orthopoxviruses.[1][1] It was approved by Health Canada for the treatment of smallpox in November 2021 and approved in other jurisdictions for the treatment of cowpox, MPXV and smallpox.[2][2] Studies involving animals infected with smallpox